Improving Drug Delivery for Brain Tumor Treatment

Scientists propose combining ultrasound with other techniques to improve drug transport into brain tumors.


  • newswise-fullscreen Improving Drug Delivery for Brain Tumor Treatment

    Credit: Proceedings of the National Academy of Sciences

    Sequential intravital multiphoton microscopy of an autofluorescence chemotherapeutic agent (red) in BT474-Gluc brain tumors (green) after FUS-mediated blood-brain barrier disruption (FUS-BBBD). White arrows show increased drug extravasation and penetration after FUS-BBBD (white arrows). Yellow arrows show increased doxorubicin transmembrane transport in endothelial cells after FUS-BBBD. The bottom left and right images were collected 2 and 5 minutes after drug administration respectively. Scale bar 30 µm.

Newswise — SAN DIEGO, December 2, 2019 -- Despite improvements in drug delivery mechanisms, treating brain tumors has remained challenging.

Costas Arvanitis, of Georgia Institute of Technology, studies the processes affecting therapeutic drug penetration into brain tumors. He will present two strategies for improving the delivery of therapeutic agents during a session at the 178th Meeting of the Acoustical Society of America, which will take place Dec. 2-6, at the Hotel del Coronado in San Diego.

The talk, “Controlled drug delivery and release in brain tumors with focused ultrasound,” will be presented at 11:30 a.m. PT, Monday, Dec. 2 as part of the session on cavitation nuclei.

“For a bloodborne therapeutic agent to be effective, it must cross the blood vessel wall to reach cancer cells in adequate quantities,” said Arvanitis. “However, tumors can thwart their effectiveness in many ways.”

While tumors are known to compromise the integrity of the blood brain barrier -- a specialized vessel wall evolved to keep the brain “safe” -- the makeup of the barrier is inconsistent, which prevents drugs from being uniformly distributed throughout the tumor. Unfortunately, increasing dosages to help improve drug delivery is not possible due to the adverse effects caused by drug interactions with healthy tissue, and drug penetration to the tumor core remains limited.

“To overcome these obstacles, new nanoparticle drug formulations that are associated with lower toxicity and clearance times have been proposed,” he said. “Despite progress, improved nanoparticle penetration into brain tumors remains a major challenge.”

By combining focused ultrasound methods with different nanoparticle formulations, Arvanitis and his students, Yutong Guo and Chulyong Kim, have investigated two strategies for improving drug penetration into brain tumors. One approach is to use microbubbles to help overcome vascular barriers within the brain tumors and improve nanoparticle penetration across the vessel wall. The second method uses ultrasound in combination with temperature-sensitive nanoparticles. In this approach, ultrasound is used to trigger the release of the encapsulated drug only within the tumor, thereby locally increasing the drug effectiveness.

“While these concepts have been around for some time, our mechanistic investigations not only explain and underscore the potential of combining focused ultrasound with different nanoparticle formulations to treat brain cancer but also lay the groundwork for more rational design and deeper understanding of focused ultrasound-based treatment,” Arvanitis said. “Our results demonstrate that these therapeutic strategies can provide unique opportunities to improve the delivery of nanoparticles and their cargo in the brain and brain tumor microenvironment.”

###

Arvanitis’ presentation 1aBAb6, "Controlled drug delivery and release in brain tumors with focused ultrasound," will be at 11:30 a.m. PT, Monday, Dec. 2, in the Hanover room of the Hotel del Coronado in San Diego.

###

----------------------- MORE MEETING INFORMATION -----------------------

USEFUL LINKS

Main meeting website: http://acousticalsociety.org/asa-meetings/
Technical program: https://asa2019fall.abstractcentral.com/planner.jsp
Press Room: http://acoustics.org/world-wide-press-room/

WORLDWIDE PRESS ROOM

In the coming weeks, ASA's Worldwide Press Room will be updated with additional tips on dozens of newsworthy stories and with lay language papers, which are 300-500 word summaries of presentations written by scientists for a general audience and accompanied by photos, audio and video. You can visit the site during the meeting at http://acoustics.org/world-wide-press-room/.

PRESS REGISTRATION

We will grant free registration to credentialed journalists and professional freelance journalists. If you are a reporter and would like to attend, contact the AIP Media Line at 301-209-3090. For urgent requests, staff at media@aip.org can also help with setting up interviews and obtaining images, sound clips or background information.

LIVE MEDIA WEBCAST

Press briefings will be webcast live from the conference Tuesday, Dec. 3, in Hospitality Suite 3103 of the Hotel del Coronado in San Diego. Register at https://webcast.aipwebcasting.com/go/asa-dec3-19 to watch the live webcast. The schedule will be posted at the same site as soon as it is available.

ABOUT THE ACOUSTICAL SOCIETY OF AMERICA

The Acoustical Society of America (ASA) is the premier international scientific society in acoustics devoted to the science and technology of sound. Its 7,000 members worldwide represent a broad spectrum of the study of acoustics. ASA publications include The Journal of the Acoustical Society of America (the world's leading journal on acoustics), Acoustics Today magazine, books, and standards on acoustics. The society also holds two major scientific meetings each year. For more information about ASA, visit our website at http://www.acousticalsociety.org.

###

Chat now!
1.28566